TMEM51-AS1: A Potential Drug Target and Biomarker (G200197)

Target Name: TMEM51-AS1

NCBI ID: G200197

TMEM51-AS1

Other Name(s): TMEM51 antisense RNA 1 | C1orf126

TMEM51-AS1: A Potential Drug Target and Biomarker

TMEM51-AS1, also known as TMEM51-AS1 gene, is a non-coding RNA molecule that has been identified in various organisms, including humans. It plays a crucial role in the regulation of cell proliferation and has been implicated in various diseases, including cancer. In this article, we will discuss the potential drug target and biomarker properties of TMEM51-AS1.

The TMEM51-AS1 gene is located on chromosome 6p21.2 and has been shown to encode a protein that is involved in the regulation of cell adhesion, migration, and invasion. TMEM51-AS1 has also been shown to play a role in the regulation of cell cycle progression and has been linked to the development of cancer.

TMEM51-AS1 has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and colorectal cancer. It has also been shown to contribute to the development of resistance to chemotherapy in cancer cells.

Recent studies have suggested that TMEM51-AS1 may be a potential drug target for cancer treatment. By inhibiting the activity of TMEM51-AS1, researchers have found that they can reduce the growth and survival of cancer cells. This suggests that TMEM51-AS1 may be an effective target for cancer treatment.

In addition to its potential as a drug target, TMEM51-AS1 has also been shown to be a potential biomarker for cancer. Its expression has been shown to be elevated in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that TMEM51-AS1 may be a useful biomarker for the diagnosis and monitoring of cancer.

TMEM51-AS1 has also been shown to play a role in the regulation of stem cell proliferation and differentiation. It has been shown to promote the self-renewal and survival of stem cells, which may have implications for the development of cancer.

In conclusion, TMEM51-AS1 is a non-coding RNA molecule that has been shown to play a crucial role in the regulation of cell proliferation and has been implicated in various diseases, including cancer. Its potential as a drug target and biomarker properties make it an attractive target for further research. Further studies are needed to fully understand the role of TMEM51-AS1 in cancer and to develop effective treatments.

Protein Name: TMEM51 Antisense RNA 1

The "TMEM51-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM51-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets